Investment Banking

Investment Banking 2023-02-14T16:53:00+00:00

Seeing all sides, and knowing what matters.

Sectors of Focus

10 b - Investment Banking
M&A Transactions
25 m - Investment Banking
TRANSACTION SIZE
continents - Investment Banking
CONTINENTS

Seeing all sides, and knowing what matters.

Sectors of Focus

icon pharma - Investment Banking
PHARMACEUTICALS
icon services - Investment Banking
PHARMACEUTICAL SERVICES
icon health - Investment Banking
CONSUMER HEALTH & OTC

Typical Transaction

  • Sell-side M&A
  • Capital raising

EXPERIENCE + UNDERSTANDING

The Bourne Partners investment banking team understands opportunities from every angle and we concentrate on what’s important to you.

block-contipi-indegene

ConTIPI Medical Ltd provides non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFDs). ConTIPI’s first device for stress urinary incontinence (SUI), the Impressa device, was acquired by Kimberly Clark Worldwide and is available for sale. ConTIPI’s following innovation is the ProVate Device, intended to manage Pelvic Organ Prolapse (POP) in women.

SECTOR: Medical Device; Tech-Enabled Services
YEAR: May 2023
DEAL SIZE: Undisclosed
MANDATE TYPE: Commercialization

block-contipi-capIP-GTP

ConTIPI Medical Ltd provides non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFDs). ConTIPI’s first device for stress urinary incontinence (SUI), the Impressa device, was acquired by Kimberly Clark Worldwide and is available for sale. ConTIPI’s following innovation is the ProVate Device, intended to manage Pelvic Organ Prolapse (POP) in women.

SECTOR: Medical Device
YEAR: May 2023
DEAL SIZE: $40,000,000
MANDATE TYPE: Capital Raise

block-uphealth-medquest

UpHealth is a global digital health company that delivers digital-first technology, infrastructure, and services to dramatically improve how healthcare is delivered and managed. Innovations Group (“IGI”) is a group of companies / business units focused on providing integrative medicine and preventative health solutions for patients and prescribers through its 503A compounding pharmacy, CME accredited training and education platform, clinical grade supplements line, and analytical testing support services.

SECTOR: Pharmacy Services
YEAR: February 2023
DEAL SIZE: $56,000,000
MANDATE TYPE: Sell-Side Advisory

block-tapemark-LTS

Founded in 1952, Tapemark’s first service offering was printing on self-wound tape. As an early leader in pressure-sensitive adhesives, their expertise evolved to include single-use medical and personal care products. Today, Tapemark specializes in the development and manufacturing of multiple drug delivery systems delivering both Rx and OTC pharmaceuticals via transdermal patches, oral films, and unit dose topical applicators.

SECTOR: Pharmaceuticals
YEAR: August 2022
DEAL SIZE: Undisclosed
MANDATE TYPE: Sell-Side M&A Advisory

block-oakrum-ani

Oakrum Pharma, LLC is a privately-owned biopharmaceutical company focusing on development and commercialization of affordable drug therapies, located in St. Louis, Missouri. Through a business model of collaborating with experts in various disciplines and leveraging a global network of business partners, Oakrum Pharma intends to provide more options to small, specialty and rare disease markets.

SECTOR: Pharmaceuticals
YEAR: July 2022
DEAL SIZE: Undisclosed
MANDATE TYPE: Sell-Side M&A Advisory

block-fagron-signet

Fagron is a global, vertically integrated pharmaceutical company delivering personalized medical solutions safely to over 300,000 patient-focused customers. Fagron focuses on optimizing and innovating pharmaceutical compounding to widen the therapeutic scope of prescribers worldwide.

SECTOR: Pharmaceuticals
YEAR: February 2022
DEAL SIZE: Up to $10,000,000
MANDATE TYPE: Sell-Side Advisory

block-woodward-colbeck

Woodward Pharma Services LLC is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market.  Woodward Pharma provides outsourced marketing, sales, and commercial services for the US pharmaceutical industry.

SECTOR: Specialty Pharma
YEAR: July 2021
DEAL SIZE: $125,000,000
MANDATE TYPE: Capital Raise

block-nuvera-udg

Nuvera Life Science is a consulting company dedicated to helping its clients design, build and manage a seamless patient and HCP treatment experience for rare disease and specialty therapeutics.

SECTOR: Pharma Services
YEAR: May 2021
DEAL SIZE: Up to $36 million
MANDATE TYPE: Company Sell-side

block-ani-novitium

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

SECTOR: Generic Pharma
YEAR: March 2021
DEAL SIZE: up to $249,000,000
MANDATE TYPE: Company Buy-side

block-provepharm apollo

Apollo USA is the US subsidiary of Apollo Pharmaceuticals Inc. focused on establishing and commercializing a sterile injectable platform in the US.

SECTOR: Pharma
YEAR: December 2020
DEAL SIZE: Undisclosed
MANDATE TYPE: Company sell-side

block-american injectables new rhein

American Injectables is a US-based sterile injectable manufacturer of parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials.

SECTOR: Pharma
YEAR: September 2020
DEAL SIZE: $10 million
MANDATE TYPE: Series A Financing

block-ivc acella

International Vitamin Corporation (“IVC”) is an industry leading supplier of vitamins and nutritional/dietary supplement products.

SECTOR: Pharma
YEAR: May 2020
DEAL SIZE: Undisclosed
MANDATE TYPE: Asset Divestiture

CONNECTION + COLLABORATION

We collaborate with industry stakeholders and draw on strong relationships on both the advisory and strategic capital sides.

And we don’t stop until the deal is done.